Project duration: 01.2021 – 12.2023 (Finalised)
Project description: Patient Blood Management is an evidence-based, multidisciplinary approach to caring for patients who might need a blood transfusion. Platelets are the second most commonly transfused cellular blood component, and is mainly indicated to treat or prevent bleeding in patients with thrombocytopenia or platelet function disorder. The increased demand and limited supply of platelet products show that judicious use of platelet transfusions is crucial. Read more
Project duration: 01.07.2021-30.06.2023 (Finalised)
Project description: Neonates (newborn babies) are a highly transfused group, but robust evidence supporting transfusion practice is lacking, with significant variation in patterns of use as a result. Recent trials indicate little benefit from transfusing at liberal thresholds and in some cases even report evidence of harm. We aim to perform a point prevalence study to describe prevalence, indications, and component specifications of transfusions among preterm neonates in Europe. This will be the first Europe-wide study to generate neonatal transfusion benchmark data for all participating EBA members. It will highlight areas to improve practice and inform research gaps, while contributing to developing European neonatal transfusion guidelines, the design of new research studies, and a review of component specifications for neonates to match recipient needs. Read more